109
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Solid lipid nanoparticles of lutein with improved dissolution behavior and oral absorption

, , , , &
Pages 877-883 | Received 20 Jun 2023, Accepted 09 Oct 2023, Published online: 18 Oct 2023

References

  • Aman R, Schieber A, Carle R. 2005. Effects of heating and illumination on trans-cis isomerization and degradation of β-carotene and lutein in isolated spinach chloroplasts. J Agric Food Chem. 53(24):9512–9518. doi: 10.1021/jf050926w.
  • Baek J, Cho C. 2017. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur J Pharm Biopharm. 117:132–140. doi: 10.1016/j.ejpb.2017.04.013.
  • Banik S, Yamada K, Sato H, Onoue S. 2022. Development of poly(lipoic acid) nanoparticles with improved oral bioavailability and hepatoprotective effects of quercetin. Mol Pharm. 19(5):1468–1476. doi: 10.1021/acs.molpharmaceut.2c00009.
  • Chew E, Clemons T, SanGiovanni J, Danis R, Ferris F, Elman M, Antoszyk A, Ruby A, Orth D, Bressler S, et al. 2013. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA. 309(19):2005–2015. doi: 10.1001/jama.2013.4997.
  • de Boer F, Imhof A, Velikov K. 2020. Photo-stability of lutein in surfactant-free lutein-zein composite colloidal particles. Food Chem X. 5:100071. doi: 10.1016/j.fochx.2019.100071.
  • Gomez R, Goni F, Macarulla J. 1978. Carotenoids from marigold (Tagetes erecta) petals and their esterified fatty acids. Rev Esp Fisiol. 34(3):253–256.
  • Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge G, Higaki K, Kimura T. 2006. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 111(1–2):56–64. doi: 10.1016/j.jconrel.2005.11.013.
  • Johnson BK, Prud’homme RK. 2003. Mechanism for rapid self-assembly of block copolymer nanoparticles. Phys Rev Lett. 91(11):118302. doi: 10.1103/PhysRevLett.91.118302.
  • Johnson B, Saad W, Prud’homme R. 2006. Nanoprecipitation of pharmaceuticals using mixing and block copolymer stabilization. ACS Symposium Series. 924:278–291. doi: 10.1021/bk-2006-0924.ch018.
  • Krinsky N, Johnson E. 2005. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 26(6):459–516. doi: 10.1016/j.mam.2005.10.001.
  • Landrum J, Bone R. 2001. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 385(1):28–40. doi: 10.1006/abbi.2000.2171.
  • Li L, Lee J, Leung H, Lam W, Fu Z, Lo A. 2020. Lutein supplementation for eye diseases. Nutrients. 12(6):1721. doi: 10.3390/nu12061721.
  • Lim C, Kim D, Sim T, Hoang N, Lee J, Lee E, Youn Y, Oh K. 2016. Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops. J Drug Deliv Sci Technol. 36:168–174. doi: 10.1016/j.jddst.2016.10.009.
  • Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, Xu XR, Zou ZY, Dong PC, Xiao X, et al. 2012. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 119(11):2290–2297. doi: 10.1016/j.ophtha.2012.06.014.
  • Markwalter CE, Prud’homme RK. 2018. Design of a small-scale multi-inlet vortex mixer for scalable nanoparticle production and application to the encapsulation of biologics by inverse flash NanoPrecipitation. J Pharm Sci. 107(9):2465–2471. doi: 10.1016/j.xphs.2018.05.003.
  • Mendoza-Muñoz N, Urbán-Morlán Z, Leyva-Gómez G, de LL, Zambrano-Zaragoza M, Piñón-Segundo E, Quintanar-Guerrero D. 2021. Solid lipid nanoparticles: an approach to improve oral drug delivery. J Pharm Pharm Sci. 24:509–532. doi: 10.18433/jpps31788.
  • Onoue S, Igarashi N, Yamada S, Tsuda Y. 2008. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances. J Pharm Biomed Anal. 46(1):187–193. doi: 10.1016/j.jpba.2007.09.003.
  • Onoue S, Seto Y, Gandy G, Yamada S. 2009. Drug-induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr Drug Saf. 4(2):123–136. doi: 10.2174/157488609788173044.
  • Onoue S, Tsuda Y. 2006. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm Res. 23(1):156–164. doi: 10.1007/s11095-005-8497-9.
  • Rajpoot K. 2019. Solid lipid nanoparticles: a promising nanomaterial in drug delivery. Curr Pharm Des. 25(37):3943–3959. doi: 10.2174/1381612825666190903155321.
  • Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J. 2004. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 75(4):216–230. doi: 10.1016/s1529-1839(04)70049-4.
  • Sato Y, Kobayashi M, Itagaki S, Hirano T, Noda T, Mizuno S, Sugawara M, Iseki K. 2011. Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein. Biopharm Drug Dispos. 32(3):151–158. doi: 10.1002/bdd.746.
  • Seto Y, Ueno K, Suzuki H, Sato H, Onoue S. 2019. Development of novel lutein nanocrystal formulation with improved oral bioavailability and ocular distribution. J Funct Foods. 61:103499. doi: 10.1016/j.jff.2019.103499.
  • Shanmugam S, Park J, Kim K, Piao Z, Yong C, Choi H, Woo J. 2011. Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS). Int J Pharm. 412(1-2):99–105. doi: 10.1016/j.ijpharm.2011.04.015.
  • Tanaka Y, Hara T, Waki R, Nagata S. 2012. Regional differences in the components of luminal water from rat gastrointestinal tract and comparison with other species. J Pharm Pharm Sci. 15(4):510–518. doi: 10.18433/j3f602.
  • Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C. 2005. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm. 60(3):413–417. doi: 10.1016/j.ejpb.2005.03.002.
  • Vertzoni M, Fotaki N, Nicolaides E, Reppas C, Kostewicz E, Stippler E, Leuner C, Dressman J. 2004. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J Pharm Pharmacol. 56(4):453–462. doi: 10.1211/0022357022935.
  • Yoo J, Shanmugam S, Thapa P, Lee E, Balakrishnan P, Baskaran R, Yoon S, Choi H, Yong C, Yoo B, et al. 2010. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch Pharm Res. 33(3):417–426. doi: 10.1007/s12272-010-0311-5.
  • Yousef M, Silva D, Chacra N, Davies N, Löbenberg R. 2021. The lymphatic system: A sometimes-forgotten compartment in pharmaceutical sciences. J Pharm Pharm Sci. 24:533–547. doi: 10.18433/JPPS32222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.